Choosing What's Right for You Common Side Effects of Prostate Cancer Treatment

Presenter: Dr. Danny Vesprini
Original Date: Tuesday, February 13, 2018

Description:
This presentation is an overview of the most common and serious side effects that are possible for men who are treated for prostate cancer.  It compares and contrasts the 4 main treatment options: surgery, low dose rate (LDR; permanent seed) brachytherapy, high dose rate (HDR: temporary seed) brachytherapy, and external beam radiotherapy (EBRT).   This is a presentation that men and their families who are still undecided as to what treatment option they prefer may find useful as it compares the risk of developing a side effect of therapy (e.g. bladder leaking, rectal bleeding, etc) between the four options.  This presentation is based on the best available data in the medical literature that a collaborative group of surgeons and oncologists agreed upon to help make sure patients are provided consistent, high quality information.
   
 
 

Danny VespriniDanny Vesprini's Biography:

Dr Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.

 

About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive